Related Experiment Video
Updated: Apr 4, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
An Analysis of MIF Structural Features that Control Functional Activation of CD74
Georgios Pantouris1, Mansoor Ali Syed2, Chengpeng Fan1
1Department of Pharmacology, Yale School of Medicine, New Haven, CT 06510, USA.
Abstract:
For more than 15 years, the tautomerase active site of macrophage migration inhibitory factor (MIF) and its catalytic residue Pro1 have been being targeted for the development of therapeutics that block activation of its cell surface receptor, CD74. Neither the biological role of the MIF catalytic site nor the mechanistic details of CD74 activation are well understood. The inherently unstable structure of CD74 remains the biggest obstacle in structural studies with MIF for understanding the basis of CD74 activation. Using a novel approach, we elucidate the mechanistic details that control activation of CD74 by MIF surface residues and identify structural parameters of inhibitors that reduce CD74 biological activation. We also find that N-terminal mutants located deep in the catalytic site affect surface residues immediately outside the catalytic site, which are responsible for reduction of CD74 activation.
Insights
Targeting macrophage migration inhibitory factor (MIF) and its receptor CD74 is key for therapeutics. This study reveals how MIF
Area of Science:
- Immunology
- Biochemistry
- Structural Biology
Background:
- Macrophage migration inhibitory factor (MIF) and its receptor CD74 are key targets for therapeutic development.
- The catalytic site of MIF and the activation mechanism of CD74 are not well understood.
- The instability of CD74 hinders structural studies of MIF-CD74 interactions.
Purpose of the Study:
- To elucidate the mechanistic details of CD74 activation by MIF surface residues.
- To identify structural parameters of inhibitors that reduce CD74 biological activation.
- To understand how N-terminal MIF mutations impact CD74 activation.
Main Methods:
- Utilized a novel approach to study MIF-CD74 interactions.
- Investigated the role of MIF surface residues in CD74 activation.
- Analyzed N-terminal MIF mutants and their effect on CD74 activation.
Main Results:
- Elucidated mechanistic details controlling CD74 activation by MIF surface residues.
- Identified structural features of inhibitors that decrease CD74 biological activation.
- Demonstrated that N-terminal MIF mutations affect surface residues, reducing CD74 activation.
Conclusions:
- MIF surface residues play a critical role in CD74 activation.
- Inhibitor design can be guided by identified structural parameters to reduce CD74 activation.
- N-terminal mutations within MIF's catalytic site can allosterically modulate CD74 activation through surface residue interactions.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Master Transcription Regulators
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

